Anticipated shortage
Crestor 10 mg tablets
rosuvastatin · 10 mg tablet
Crestor
- Reported
- 22 March 2025
- Expected resolution
- 30 September 2026
- TGA reference
- TGA-MSI-2025-032
- Sponsor
- AstraZeneca Pty Ltd
Reason for shortage
Anticipated disruption as AstraZeneca transitions rosuvastatin to generic manufacturers following patent expiry.
What to do
- 1.Ensure you have adequate stock — Collect your current prescription promptly to build a small buffer before the anticipated shortage begins.
- 2.Speak with your prescriber proactively — Discuss alternative options now, before the shortage occurs, so a plan is in place.
- 3.Monitor TGA updates — Anticipated shortages may be resolved before they become active. Check the TGA MSI database regularly.
Suggested alternatives
Always discuss alternative medicines with your pharmacist or doctor before switching. Listed items are from the same or a related therapeutic class — not necessarily drop-in substitutes.
- Generic rosuvastatin 10 mg — increasing availability
- Lipitor (atorvastatin) 20 mg — potency conversion required
Official resources
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.